Document:

Exhibit 10.3

 

THIS NOTE AND ANY SECURITIES ISSUABLE
UPON THE PAYMENT HEREOF HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR UNDER THE SECURITIES LAWS OF
CERTAIN STATES. THESE SECURITIES MAY NOT BE OFFERED, SOLD OR OTHERWISE TRANSFERRED, PLEDGED OR HYPOTHECATED EXCEPT AS PERMITTED
UNDER THE ACT AND APPLICABLE STATE SECURITIES LAWS PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT OR AN EXEMPTION THEREFROM. THE
ISSUER OF THESE SECURITIES MAY REQUIRE AN OPINION OF COUNSEL REASONABLY SATISFACTORY TO THE ISSUER THAT SUCH OFFER, SALE OR TRANSFER,
PLEDGE OR HYPOTHECATION OTHERWISE COMPLIES WITH THE ACT AND ANY APPLICABLE STATE SECURITIES LAWS.

 

 

AMERICAN CARESOURCE HOLDINGS, INC.

 

SECURED PROMISSORY NOTE

 

 

	Principal: $200,000	October 6, 2016

 

 

FOR
VALUE RECEIVED, American CareSource Holdings, Inc., a Delaware corporation (the “Company”),
promises to pay to John Pappajohn (“Lender”), or Lender’s registered
assigns, the principal sum set forth above, or such lesser amount as shall equal the outstanding principal amount of this Secured
Promissory Note (this “Note”), together with interest from the date of this
Note on the unpaid principal balance as set forth herein. 

 

The following
is a statement of the rights of Lender and the conditions to which this Note is subject, and to which Lender, by the acceptance
of this Note, agrees:

 

1.      Interest
and Repayment.

 

(a)        
Interest. Interest shall accrue at a rate equal to 6.0% per annum, computed on the basis of the actual number of days elapsed
and a year of 365 days.

 

(b)        Repayment. Payment on this Note shall be made in immediately available funds, and shall be applied first to accrued interest
and thereafter to the outstanding principal balance of this Note. Interest-only payments shall be due and payable on the first
day of each calendar month beginning the first full month after the date of this Note. All outstanding principal and interest shall
be due and payable on the date that is 18 months after the date of this Note (the “Maturity Date”). The outstanding
balance of this Note may be prepaid by the Company in full or in part at any time without penalty.

 

2.      Events
of Default. The occurrence of any of the following shall constitute an “Event of Default” under this
Note:

 

(a)        Failure to Pay. The Company shall fail to pay any interest payment or other payment required under the terms of this Note
on the date due and such payment shall not have been made within five (5) business days of the Company’s receipt of written
notice to the Company of such failure to pay; or

 

    	 	- 1 -	 

     

    

(b)        Breaches of Covenants. The Company shall fail to observe or perform any other covenant, obligation, condition or agreement
contained in this Note (other than those specified in Section 2(a)) and such failure shall continue for ten (10) business
days after the Company’s receipt of written notice to the Company of such failure; or

 

(c)        Voluntary Bankruptcy or Insolvency Proceedings. The Company shall (i) apply for or consent to the appointment of a
receiver, trustee, liquidator or custodian of itself or of all or a substantial part of its property, (ii) admit in writing
its inability to pay its debts generally as they mature, (iii) make a general assignment for the benefit of its or any of
its creditors, (iv) be dissolved or liquidated, (v) commence a voluntary case or other proceeding seeking liquidation,
reorganization or other relief with respect to itself or its debts under any bankruptcy, insolvency or other similar law now or
hereafter in effect or consent to any such relief or to the appointment of or taking possession of its property by any official
in an involuntary case or other proceeding commenced against it, or (vi) take any action for the purpose of effecting any
of the foregoing; or

 

(d)        Involuntary Bankruptcy or Insolvency Proceedings. Proceedings for the appointment of a receiver, trustee, liquidator or
custodian of the Company, or of all or a substantial part of the property thereof, or an involuntary case or other proceedings
seeking liquidation, reorganization or other relief with respect to the Company or any of its subsidiaries, if any, or the debts
thereof under any bankruptcy, insolvency or other similar law now or hereafter in effect shall be commenced and an order for relief
entered or such proceeding shall not be dismissed or discharged within 45 days of commencement.

 

3.      Rights
of Lender upon Default. Upon the occurrence of any Event of Default described in Sections 2(a) or 2(b), and at any time
thereafter during the continuance of such Event of Default, Lender may, by written notice to the Company, declare all outstanding
principal and interest to be immediately due and payable without presentment, demand, protest or any other notice of any kind,
all of which are hereby expressly waived, anything contained herein to the contrary notwithstanding. Upon the occurrence of any
Event of Default described in Sections 2(c) or 2(d), immediately and without notice, all outstanding principal and interest
shall become immediately due and payable, without presentment, demand, protest or any other notice of any kind, all of which are
hereby expressly waived, anything contained herein to the contrary notwithstanding. In addition to the foregoing remedies, upon
the occurrence and during the continuance of any Event of Default, Lender may exercise any other right power or remedy granted
to it or permitted to it by law, either by suit in equity or by action at law, or both.

 

4.      Note
Delivery. Upon the Company’s satisfaction of all amounts due under this Note, Lender shall deliver the original of
this Note (or a notice to the effect that the original Note has been lost, stolen or destroyed and an agreement acceptable to the
Company whereby the holder agrees to indemnify the Company from any loss incurred by it in connection with this Note) for cancellation,
provided that Company shall be forever released from all its obligations and liabilities under this Note upon making such payment
in full and this Note shall be deemed of no further force or effect, whether or not the original of this Note has been delivered
to the Company for cancellation.

 

5.      Representations
and Warranties of the Lender. Lender hereby represents and warrants to the Company as follows:

 

(a)        Securities Law Compliance. Lender has been advised that this Note has not been registered under the Securities Act of 1933,
as amended (the “Act”) or any state securities laws and, therefore, cannot be resold unless it is registered
under the Act and applicable state securities laws or (if this Note is deemed to be securities) unless an exemption from such registration
requirements is available. Lender is aware that the Company is under no obligation to effect any such registration with respect
to this Note or to file for or comply with any exemption from registration. If Lender is an entity, Lender has not been formed
solely for the purpose of making this investment and is entering into the transaction contemplated by this Note for Lender’s
own account for investment, not as a nominee or agent, and not with a view to, or for resale in connection with, the distribution
thereof. Lender has such knowledge and experience in financial and business matters that Lender is capable of evaluating the merits
and risks of such investment, is able to incur a complete loss of such investment, and is able to bear the economic risk of such
investment for an indefinite period of time. Lender is an “accredited investor” as such term is defined in Rule 501
of Regulation D under the Act.

 

    	 	- 2 -	 

     

    

(b)        Access to Information. Lender acknowledges that the Company has given the Lender access to the corporate records and accounts
of the Company and to all information in its possession relating to the Company, has made its officers and representatives available
for interview by Lender, and has furnished Lender with all documents and other information required for Lender to make an informed
decision with respect to the purchase of the Note.

 

6.      Representations
and Warranties of the Company. The Company hereby represents and warrants to the Lender as follows:

 

(a)        Organization, Good Standing, Qualification and Power. The Company is duly organized, validly existing and in good standing
under the laws of its state of incorporation. The Company has the requisite corporate power to own and operate its properties and
assets and to carry on its business as now conducted and as proposed to be conducted. The Company is duly qualified and is authorized
to do business and is in good standing as a foreign entity in all jurisdictions in which the nature of its activities and of its
properties (both owned and leased) makes such qualification necessary, except for those jurisdictions in which failure to do so
would not have a material adverse effect on the Company or its business. The Company has all requisite corporate power to execute
and deliver the Note and to carry out and perform its obligations hereunder and thereunder.

 

(b)        Authorization. All requisite corporate action has been taken on the part of the Company necessary for the authorization
of the Note and the execution, delivery and performance of all obligations of the Company under the Note.

 

7.      Security.

 

(a)        Security Interest. As security for the Company’s payment and performance under this Note, the Company hereby grants
to Lender a security interest in all of the Company’s assets including the following (collectively, the “Collateral”):
(a) machinery, tools, equipment, furniture, furnishings and fixtures, of every kind and nature, movable or immovable, wherever
located and whether now or hereafter existing, and all parts thereof and replacements, additions, improvements and accessions thereto;
(b) accounts, deposit accounts, accounts receivable, chattel paper (whether tangible or electronic), records, documents (whether
negotiable or non-negotiable), instruments (whether negotiable or non-negotiable), investment property and other obligations owed
to the Company of any kind, whether or not evidenced by an instrument or chattel paper, and whether or not such asset has been
earned by performance, whether now or hereafter existing, (c) contract rights and general intangibles, both now owned and hereafter
acquired, and (d) all proceeds from any of the items listed in clauses (a)-(c) of this subsection. The Company hereby authorizes
Lender to file any financing statement or other evidence of the security interest granted in this Section 7. The Company shall
promptly execute and deliver, at its sole cost and expense, all financing statements, instruments and other documents, and take
all further action that Lender may reasonably request from time to time to perfect and protect the security interest created herein.

 

    	 	- 3 -	 

     

    

(b)        Prior Liens. Notwithstanding the foregoing, Lender acknowledges that the liens in, on or with respect to the Collateral
granted by Borrower in this Note are expressly subordinated and made junior in right, priority, operation and effect to any and
all liens granted to (and not released by) any other creditor prior to the date of this Note, including without limitation, to
the liens of Wells Fargo Bank, N.A.. Such subordination shall be effective irrespective of the time, order or method of creation,
attachment or perfection of any such prior liens granted in favor of the applicable creditors or of any defect or deficiency or
alleged defect or deficiency in any such prior lien.

 

8.      Miscellaneous.

 

(a)        Successors and Assigns; Transfer of this Note. The rights and obligations of the Company and Lender shall be binding upon
and benefit the successors, assigns, heirs, administrators and transferees of the parties; provided that neither this Note nor
any of the rights, interests or obligations hereunder may be assigned, by operation of law or otherwise, in whole or in part, by
the Company without the prior written consent of Lender.

 

(b)        Waiver and Amendment. Any provision of this Note may be amended, waived or modified only upon the written consent of the
Company and Lender.

 

(c)        Broker or Finders Fee. Each of the Company and Lender hereby represents and warrants to the other party that it has not
incurred, and will not incur, directly or indirectly, as a result of any action taken by it or its agents, any liability for brokerage
or finders’ fees or agents’ commissions or any similar charges in connection with the issuance of this Note or any
of the transactions contemplated hereby.

 

(d)        Notices. All notices, requests, demands, consents, instructions or other communications required or permitted hereunder
shall be in writing and faxed, mailed or delivered to each party at the respective addresses of the parties as set forth on the
signature pages to this Note, or at such other address or facsimile number as the Company shall have furnished to Lender in writing.
All such notices and communications will be deemed effectively given the earlier of (i) when received, (ii) when delivered
personally, (iii) one business day after being deposited with an overnight courier service of recognized standing or (iv) four
days after being deposited in the U.S. mail, first class with postage prepaid.

 

(e)        Usury. In the event any interest is paid on this Note which is deemed to be in excess of the then legal maximum rate, then
that portion of the interest payment representing an amount in excess of the then legal maximum rate shall be deemed a payment
of principal and applied against the principal of this Note.

 

(f)         Governing Law. This Note and all actions arising out of or in connection with this Note shall be governed by and construed
in accordance with the laws of the State of Delaware without regard to the conflicts of law provisions of the State of Delaware,
or of any other state.

 

    	 	- 4 -	 

     

    

(g)        Waiver of Jury Trial. By acceptance of this Note, Lender hereby agrees and the Company hereby agrees to waive their respective
rights to a jury trial of any claim or cause of action based upon or arising out of this Note.

 

(h)        Counterparts. This Note may be executed in any number of counterparts and by different parties on separate counterparts,
each of which, when executed and delivered, shall be deemed to be an original, and all of which, when taken together, shall constitute
but one and the same Note.

 

 

 

(Signature Page Follows)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

    	 	- 5 -	 

     

    

 

The Company has caused this Note to be issued as of the date first
written above.

 

 

 

	 	AMERICAN CARESOURCE HOLDINGS, INC.
	 	 	 	 	 
	 	 	 	 	 
	 	 	By:	/s/ Adam S. Winger	 
	 	 	Name:	Adam S. Winger	 
	 	 	Title:	President & CEO	 

 

 

	 	Address: 	GoNow Doctors
	 	 	55 Ivan Allen Jr. Blvd, Suite 510
	 	 	Atlanta, Georgia 30309 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

- 6 -EXHIBIT 10.1

 

October __, 2016

 

________________________

________________________

________________________

Attention: _______________

 

Dear Sirs:

 

This agreement (the “Amended Leak-Out
Agreement”) amends and restates in its entirety that certain leak-out agreement, by and between Great Basin Scientific,
Inc., a Delaware corporation, with headquarters located at 420 E. South Temple, Suite 520, Salt Lake City, UT 84111 (the “Company”)
and ________________ (the “Holder”), dated September 19, 2016 (as amended prior to the date hereof, the “Original
Leak Out Agreement”).

 

Reference is hereby made to (a) that certain
Securities Purchase Agreement, dated December 28, 2015, by and among the Company, the Holder and certain other buyers signatory
thereto (the “2015 SPA”), pursuant to which the Holder acquired (i) senior secured convertible notes (the “2015
Holder Notes”) and (ii) warrants to acquire shares of Common Stock (as defined in the 2015 SPA) (the “2015 Holder
Warrants”), (b) that certain Securities Purchase Agreement, dated June 29, 2016, by and among the Company, the Holder
and certain other buyers signatory thereto (the “2016 SPA”, and together with the 2015 SPA, collectively, the
“SPA”), pursuant to which the Holder acquired (i) senior secured convertible notes (the “2016 Holder
Notes”, and together with the 2015 Holder Notes, the “Holder Notes”) and (ii) warrants to acquire
shares of Common Stock as (the “2016 Holder Warrants”, and together with the 2015 Holder Warrants, the “Holder
Warrants”), (c) the Original Leak-Out Agreement and (d) that certain Exchange Agreement, dated October 2, 2016, by and
between the Holder and the Company (the “Exchange Agreement”), pursuant to which, among other things, the parties
(i) amended the percentage in paragraph 3 of the Original Leak Out Agreement to 40% of the Holder’s pro rata share of aggregate
principal amount of 2015 Notes (as defined in the Exchange Agreement) then outstanding and (ii) agreed that the terms of the Original
Leak-Out Agreement would not apply to the period commencing on and including October 17, 2016 and ending and including October
21, 2016 (the “Unrestricted Period”). This Amended Leak-Out Agreement amends and restates the Original Leak-Out
Agreement solely to eliminate the Unrestricted Period. Capitalized terms not defined herein shall have the meaning as set forth
in the applicable SPA.

 

     

     

    

 

During the period commencing on the later
of the date hereof and the first day hereafter on which all the Other Holders (as defined below) have duly executed and delivered
an amended leak-out agreement identical to this Amended Leak-Out Agreement (other than the identity of the Holder and the permitted
percentage of trading volume) (the “Effective Date”) and ending on November 1, 2016 (such period, the "Restricted
Period"), neither the Holder, nor any of its Buyer Trading Affiliates (as defined in the 2015 SPA), collectively, shall
sell, directly or indirectly, (including, without limitation, any sales, short sales, swaps or any derivative transactions that
would be equivalent to any sales or short positions) on any Trading Day during the Restricted Period (any such date, a “Date
of Determination”), more than ____1% of the trading volume of Common Stock on the Principal Market (or such
other primary market in which the Common Stock is then trading) as reported by Bloomberg, LP for the applicable Date of Determination;
provided, that the foregoing restrictions shall not apply to any actual “long” (as defined in Regulation SHO of the
Securities Exchange Act of 1934, as amended) sales by the Holder or any of its Buyer Trading Affiliates at a price greater than
either (x) $5.50 or (y) 120% of the Closing Bid Price (as defined in the Holder Notes) of the Common Stock on the Principal Market
(or such other primary market in which the Common Stock is then trading) as reported by Bloomberg, LP as of the close of business
of the Trading Day immediately prior to such Date of Determination (in each case, as adjusted for stock splits, stock dividends,
stock combinations, recapitalizations or other similar events occurring after the date hereof) (each such transfer a “Permitted
Transfer”).

 

Notwithstanding anything herein to the contrary,
during the Restricted Period, the Holder may, directly or indirectly, sell or transfer all, or any part, of the Holder Notes or
Holder Warrants (or any securities issuable upon conversion or exercise of any Holder Notes or Holder Warrants, as applicable)
(the “Restricted Securities”) to any Person (an “Assignee”) without complying with (or otherwise
limited by) the restrictions set forth in this Amended Leak-Out Agreement; provided, that as a condition to any such sale or transfer
an authorized signatory of the Company and such Assignee duly execute and deliver an agreement in the form of this Amended Leak-Out
Agreement (an “Assignee Agreement”) and sales of the Holder and its Buyer Trading Affiliates and all Assignees
(other than Permitted Transfers) shall be aggregated for all purposes of this Amended Leak-Out Agreement and all Assignee Agreements.

 

The Company shall, on or before 9:30 a.m.,
New York City time, on October 17, 2016, issue a Current Report on Form 8-K attaching this Amended Leak-Out Agreement as an exhibit
thereto (including all attachments, the “8-K Filing”) disclosing all material terms of the transactions contemplated
hereby. From and after the filing of the 8-K Filing, the Holder shall not be in possession of any material, nonpublic information
received from the Company or any of its Subsidiaries or any of their respective officers, directors, employees, affiliates or agents,
that is not disclosed in the 8-K Filing. The Company shall not, and shall cause its officers, directors, employees, affiliates
and agents, not to, provide the Holder with any material, nonpublic information regarding the Company from and after the filing
of the 8-K Filing without the express written consent of the Holder. To the extent that the Company delivers any material, non-public
information to the Holder without the Holder's express prior written consent, the Company hereby covenants and agrees that the
Holder shall not have any duty of confidentiality to the Company, any of its Subsidiaries or any of their respective officers,
directors, employees, affiliates or agent with respect to, or a duty to the to the Company, any of its Subsidiaries or any of their
respective officers, directors, employees, affiliates or agent or not to trade on the basis of, such material, non-public information.
The Company shall not disclose the name of the Holder in any filing, announcement, release or otherwise, unless such disclosure
is required by law or regulation. In addition, effective upon the filing of the 8-K Filing, the Company acknowledges and agrees
that any and all confidentiality or similar obligations under any agreement, whether written or oral, between the Company, any
of its Subsidiaries or any of their respective officers, directors, affiliates, employees or agents, on the one hand, and the older
or any of its affiliates, on the other hand, shall terminate and be of no further force or effect. The Company understands and
confirms that the Holder will rely on the foregoing representations in effecting transactions in securities of the Company.

 

 

1 Insert
Holder's pro rata portion of 40% based upon the aggregate principal amount of 2015 Holder Note held by the Holder on September
19, 2016.

 

     

     

    

 

Any notices, consents, waivers or other
communications required or permitted to be given under the terms of this Amended Leak-Out Agreement must be in writing in accordance
with the information set forth in the SPA.

 

This Amended Leak-Out Agreement constitutes
the entire agreement among the parties hereto with respect to the subject matter hereof and supersedes all prior negotiations,
letters and understandings relating to the subject matter hereof (including, without limitation, the Original Leak-Out Agreement)
and are fully binding on the parties hereto.

 

This Amended Leak-Out Agreement may be executed
simultaneously in any number of counterparts. Each counterpart shall be deemed to be an original, and all such counterparts shall
constitute one and the same instrument. This Amended Leak-Out Agreement may be executed and accepted by facsimile or PDF signature
and any such signature shall be of the same force and effect as an original signature.

 

The terms of this Amended Leak-Out Agreement
shall be binding upon and shall inure to the benefit of each of the parties hereto and their respective successors and assigns.

 

This Amended Leak-Out Agreement may not
be amended or modified except in writing signed by each of the parties hereto.

 

All questions concerning the construction,
validity, enforcement and interpretation of this letter agreement shall be governed by the internal laws of the State of New York,
without giving effect to any choice of law or conflict of law provision or rule (whether of the State of New York or any other
jurisdictions) that would cause the application of the laws of any jurisdictions other than the State of New York. Each party hereby
irrevocably submits to the exclusive jurisdiction of the state and federal courts sitting in The City of New York, Borough of Manhattan,
for the adjudication of any dispute hereunder or in connection herewith or with any transaction contemplated hereby or discussed
herein, and hereby irrevocably waives, and agrees not to assert in any suit, action or proceeding, any claim that it is not personally
subject to the jurisdiction of any such court, that such suit, action or proceeding is brought in an inconvenient forum or that
the venue of such suit, action or proceeding is improper.

 

     

     

    

 

Each party hereby irrevocably waives personal
service of process and consents to process being served in any such suit, action or proceeding by mailing a copy thereof to such
party at the address for such notices to it under this letter agreement and agrees that such service shall constitute good and
sufficient service of process and notice thereof. Nothing contained herein shall be deemed to limit in any way any right to serve
process in any manner permitted by law. Nothing contained herein shall be deemed to limit in any way any right to serve process
in any manner permitted by law. Each party hereby irrevocably waives any right it may have, and agrees not to request, a jury trial
for the adjudication of any dispute hereunder or in connection with or arising out of this letter agreement or any transaction
contemplated hereby.

 

Each party hereto acknowledges that, in
view of the uniqueness of the transactions contemplated by this letter agreement, the other parties hereto may not have an adequate
remedy at law for money damages in the event that this Amended Leak-Out Agreement has not been performed in accordance with its
terms, and therefore agrees that such other parties shall be entitled to seek specific enforcement of the terms hereof in addition
to any other remedy it may seek, at law or in equity.

 

The obligations of Holder under this Agreement
are several and not joint with the obligations of any other holder of Notes (as defined in 2015 SPA), Notes (as defined in 2016
SPA), Warrants (as defined in 2015 SPA), or Warrants (as defined in 2015 SPA) (each, an “Other Holder”) under
any other agreement, and Holder shall not be responsible in any way for the performance of the obligations of any Other Holder
under any such other agreement. Nothing contained herein or in this Agreement, and no action taken by Holder pursuant hereto, shall
be deemed to constitute Holder and Other Holders as a partnership, an association, a joint venture or any other kind of entity,
or create a presumption that Holder and the Other Holders are in any way acting in concert or as a group with respect to such obligations
or the transactions contemplated by this Agreement and the Company acknowledges that Holder and the Other Holders are not acting
in concert or as a group with respect to such obligations or the transactions contemplated by this Agreement or any other Agreement.
The Company and Holder confirms that Holder has independently participated in the negotiation of the transactions contemplated
hereby with the advice of its own counsel and advisors. Holder shall be entitled to independently protect and enforce its rights,
including, without limitation, the rights arising out of this Agreement, and it shall not be necessary for any Other Holder to
be joined as an additional party in any proceeding for such purpose.

 

     

     

    

 

The Company hereby represents and warrants
as of the date hereof and covenants and agrees from and after the date hereof that none of the terms offered to any Other Holder
with respect to any restrictions on the sale of Securities (as defined in the 2015 SPA) or Securities (as defined in the 2016 SPA)
substantially in the form of this Agreement (or any amendment, modification, waiver or release thereof) (each a “Settlement
Document”), is or will be more favorable to such Other Holder than those of the Holder and this Agreement. If, and whenever
on or after the date hereof, the Company enters into a Settlement Document, then (i) the Company shall provide notice thereof to
the Holder promptly following the occurrence thereof and (ii) the terms and conditions of this Agreement shall be, without any
further action by the Holder or the Company, automatically amended and modified in an economically and legally equivalent manner
such that the Holder shall receive the benefit of the more favorable terms and/or conditions (as the case may be) set forth in
such Settlement Document, provided that upon written notice to the Company at any time the Holder may elect not to accept the benefit
of any such amended or modified term or condition, in which event the term or condition contained in this Agreement shall apply
to the Holder as it was in effect immediately prior to such amendment or modification as if such amendment or modification never
occurred with respect to the Holder. The provisions of this paragraph shall apply similarly and equally to each Settlement Document.

 

[The remainder of the page is intentionally
left blank]

 

     

     

    

 

	 	Sincerely,
	 	 	 
	 	GREAT BASIN SCIENTIFIC, INC.
	 	 	 
	 	By: 	 
	 		Name:
	 		Title:

 

Agreed to and Acknowledged:

 

	“HOLDER”	 
	 	 	 
	 	 
	 	 	 
	 	 	 
	By: 	 	 
	 	Name:	 
	 	Title:

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00263-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00263-of-00352.parquet"}]]